An exhibition of contemporary African art by Frédéric Bruly Bouabré and Aboudia, curated by Ethan Cohen, opens at the Jamestown Arts Center May 8 through June 26, 2021. African Avant-Garde: Aboudia and Frédéric Bruly Bouabré is a juxtaposition of two African artists from the Ivory Coast. Separated by six decades of cultural history, Aboudia and Bouabré constitute the most significant and innovative artists of the post-colonial era in Africa and are on the forefront of today’s global dialog on African art.
Curator Ethan Cohen explains, “By bringing these artists’ work together, we are paying homage to two African masters of world stature. Today, Aboudia is the leading name among the new wave of young African artists impacting global consciousness. And Fréderic Bruly Bouabré is widely acknowledged as one of the seminal post-colonial African artists to achieve global recognition.”
Senators hear pros and cons of amending Article XII
mvariety.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mvariety.com Daily Mail and Mail on Sunday newspapers.
Now we re suckin diesel , Line of Duty returns to our screens
belfasttelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from belfasttelegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Product News: CN Bio’s PhysioMimix technology receives FDA recognition
13 Jan 2021
CN Bio, one of the leading developers of single and multi organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, has announced the publication of co-authored research with the U.S. Food and Drug Administration (FDA)1. The first co-published, peer-reviewed research paper between a commercial MPS provider and a regulator, demonstrates that data derived using CN Bio’s proprietary PhysioMimix™ system is appropriate for use in drug safety and metabolism applications, evidencing its enhanced performance versus standard techniques. The publication substantiates the Company’s position as a leader in the field with reliable and robust cutting-edge technology, ready for widespread adoption across the pharmaceutical industry.